Lack of ACSL4 protected CD8+ T cells from the threat of high-dose RSL3-induced ferroptosis but also resulted in functional defects of CD8+ T cells, enabling cancer cells to evade the specific killing of CD8+ T cells. The gene discussed is ACSL4; the disease is cancer.